Literature DB >> 16675778

Haemophilus influenzae forms biofilms on airway epithelia: implications in cystic fibrosis.

Timothy D Starner1, Niu Zhang, Gunhee Kim, Michael A Apicella, Paul B McCray.   

Abstract

RATIONALE: Nontypeable Haemophilus influenzae (NTHi) commonly infects patients with cystic fibrosis (CF), especially early in childhood. Bacteria biofilms are increasingly recognized as contributing to bacterial persistence and disease pathogenesis in CF.
OBJECTIVES: This study investigated ability of NTHi to form biofilms and its impact on airway epithelia using in vivo and in vitro analyses.
METHODS: We evaluated bronchoalveolar lavage fluid from young patients with CF for evidence of NTHi biofilms. To further investigate the pathogenesis of NTHi in respiratory infections, we developed a novel in vitro coculture model of NTHi biofilm formation on polarized human airway epithelial cells grown at the air-liquid interface.
MEASUREMENTS AND MAIN RESULTS: In bronchoalveolar lavage fluid samples from young, asymptomatic patients with CF, we found morphologic evidence suggestive of NTHi biofilm formation. In addition, 10 clinical NTHi isolates from patients with CF formed biofilms on plastic surfaces. NTHi formed biofilms on the apical surface of cultured airway epithelia. These biofilms exhibited decreased susceptibility to antibiotics and were adherent to epithelial surfaces. Airway epithelial cells remained viable throughout 4 d of coculture, and responded to NTHi with nuclear factor-kappaB signaling, and increased chemokine and cytokine secretion.
CONCLUSIONS: NTHi formed adherent biofilms on the apical surface airway epithelia with decreased susceptibility to antibiotics, and respiratory cells exhibited inflammatory and host defense responses-evidence of a dynamic host-pathogen interaction. The data presented here have implications both for understanding early CF lung disease pathogenesis and for the treatment of early, asymptomatic colonization of patients with CF with H. influenzae.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16675778      PMCID: PMC2662906          DOI: 10.1164/rccm.200509-1459OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  45 in total

1.  Quantification of biofilm structures by the novel computer program COMSTAT.

Authors:  A Heydorn; A T Nielsen; M Hentzer; C Sternberg; M Givskov; B K Ersbøll; S Molin
Journal:  Microbiology       Date:  2000-10       Impact factor: 2.777

2.  Direct evidence of bacterial biofilms in otitis media.

Authors:  J C Post
Journal:  Laryngoscope       Date:  2001-12       Impact factor: 3.325

3.  The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus.

Authors:  Ian Williams; W Alfred Venables; David Lloyd; Frank Paul; Ian Critchley
Journal:  Microbiology (Reading)       Date:  1997-07       Impact factor: 2.777

4.  Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B.

Authors:  S Sanlioglu; C M Williams; L Samavati; N S Butler; G Wang; P B McCray; T C Ritchie; G W Hunninghake; E Zandi; J F Engelhardt
Journal:  J Biol Chem       Date:  2001-06-11       Impact factor: 5.157

5.  Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis.

Authors:  M Rosenfeld; R L Gibson; S McNamara; J Emerson; J L Burns; R Castile; P Hiatt; K McCoy; C B Wilson; A Inglis; A Smith; T R Martin; B W Ramsey
Journal:  Pediatr Pulmonol       Date:  2001-11

6.  Identification of a lipopolysaccharide alpha-2,3-sialyltransferase from Haemophilus influenzae.

Authors:  D W Hood; A D Cox; M Gilbert; K Makepeace; S Walsh; M E Deadman; A Cody; A Martin; M Månsson; E K Schweda; J R Brisson; J C Richards; E R Moxon; W W Wakarchuk
Journal:  Mol Microbiol       Date:  2001-01       Impact factor: 3.501

7.  Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms.

Authors:  P K Singh; A L Schaefer; M R Parsek; T O Moninger; M J Welsh; E P Greenberg
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

8.  Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media.

Authors:  Garth D Ehrlich; Richard Veeh; Xue Wang; J William Costerton; Jay D Hayes; Fen Ze Hu; Bernie J Daigle; Miles D Ehrlich; J Christopher Post
Journal:  JAMA       Date:  2002-04-03       Impact factor: 56.272

9.  Haemophilus influenzae stimulates ICAM-1 expression on respiratory epithelial cells.

Authors:  A G Frick; T D Joseph; L Pang; A M Rabe; J W St Geme; D C Look
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

10.  Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung.

Authors:  Xiaorong Wang; Christian Moser; Jean-Pierre Louboutin; Elena S Lysenko; Daniel J Weiner; Jeffrey N Weiser; James M Wilson
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

View more
  72 in total

Review 1.  Bacterial biofilms in the upper airway - evidence for role in pathology and implications for treatment of otitis media.

Authors:  Lauren O Bakaletz
Journal:  Paediatr Respir Rev       Date:  2012-05-27       Impact factor: 2.726

Review 2.  Update in cystic fibrosis 2006.

Authors:  Frank J Accurso
Journal:  Am J Respir Crit Care Med       Date:  2007-04-15       Impact factor: 21.405

3.  Intercellular adhesion and biocide resistance in nontypeable Haemophilus influenzae biofilms.

Authors:  Era A Izano; Suhagi M Shah; Jeffrey B Kaplan
Journal:  Microb Pathog       Date:  2009-02-04       Impact factor: 3.738

4.  Evaluation of the kinetics and mechanism of action of anti-integration host factor-mediated disruption of bacterial biofilms.

Authors:  M Elizabeth Brockson; Laura A Novotny; Elaine M Mokrzan; Sankalp Malhotra; Joseph A Jurcisek; Rabia Akbar; Aishwarya Devaraj; Steven D Goodman; Lauren O Bakaletz
Journal:  Mol Microbiol       Date:  2014-08-19       Impact factor: 3.501

5.  Incorporation of phosphorylcholine into the lipooligosaccharide of nontypeable Haemophilus influenzae does not correlate with the level of biofilm formation in vitro.

Authors:  Carmen Puig; Sara Marti; Peter W M Hermans; Marien I de Jonge; Carmen Ardanuy; Josefina Liñares; Jeroen D Langereis
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

6.  Role of the nuclease of nontypeable Haemophilus influenzae in dispersal of organisms from biofilms.

Authors:  Christine Cho; Aroon Chande; Lokesh Gakhar; Lauren O Bakaletz; Joseph A Jurcisek; Margaret Ketterer; Jian Shao; Kenji Gotoh; Eric Foster; Jason Hunt; Erin O'Brien; Michael A Apicella
Journal:  Infect Immun       Date:  2014-12-29       Impact factor: 3.441

7.  Nontypeable Haemophilus influenzae releases DNA and DNABII proteins via a T4SS-like complex and ComE of the type IV pilus machinery.

Authors:  Joseph A Jurcisek; Kenneth L Brockman; Laura A Novotny; Steven D Goodman; Lauren O Bakaletz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

8.  Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.

Authors:  Timothy D Starner; Joshua D Shrout; Matthew R Parsek; Peter C Appelbaum; GunHee Kim
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

9.  Proteomic expression profiling of Haemophilus influenzae grown in pooled human sputum from adults with chronic obstructive pulmonary disease reveal antioxidant and stress responses.

Authors:  Jun Qu; Alan J Lesse; Aimee L Brauer; Jin Cao; Steven R Gill; Timothy F Murphy
Journal:  BMC Microbiol       Date:  2010-06-01       Impact factor: 3.605

10.  Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling.

Authors:  Chelsie E Armbruster; Wenzhou Hong; Bing Pang; Kristin E D Weimer; Richard A Juneau; James Turner; W Edward Swords
Journal:  MBio       Date:  2010-07-06       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.